StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron (REGN) Tops Q3 EPS by 31c, Offers FY Guidance
November 5, 2019 6:32 AM
Regeneron (NASDAQ: REGN) reported Q3 EPS of $6.67, $0.31 better than the analyst estimate of $6.36. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Earnings
Guidance
Next Articles
Regeneron Pharma (REGN) PT Raised to $352 at BMO Capital
November 5, 2019 3:43 PM
Regeneron (REGN) Reports Updates on Phase 3 Libtayo (cemiplimab) Development Program in Advanced NSCLC
November 5, 2019 6:44 AM
Regeneron Reports Third Quarter 2019 Financial and Operating Results
November 5, 2019 6:30 AM